A. T. Dien

Genomic characterization of metastatic breast cancers

Yahia Adnani, Thomas Bachelot, Florence Dalenc, 2019, Nature.

Genomic characterization of metastatic breast cancers

F. Bertucci, D. Birnbaum, F. André, 2019, Nature.

LBA1 Unraveling the mechanism of action and resistance to trastuzumab deruxtecan (T-DXd): Biomarker analyses from patients from DAISY trial

M. Lacroix-Triki, N. Droin, V. Diéras, 2022, Annals of Oncology.

Outcome and molecular landscape of patients with PIK3CA-mutated metastatic breast cancer.

F. Bertucci, I. Bièche, F. André, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

29P Prevalence of high tumor mutational burden (TMB) in patients with metastatic breast cancer (mBC) assessed by liquid biopsy (LB)

B. Pistilli, B. Verret, A. T. Dien, 2023, ESMO Open.

Author Correction: Genomic characterization of metastatic breast cancers

F. Bertucci, D. Birnbaum, F. André, 2019, Nature.